D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 41 Citations 9,565 106 World Ranking 3872 National Ranking 64

Overview

What is she best known for?

The fields of study she is best known for:

  • Immune system
  • Gene
  • Antibody

Her primary scientific interests are in Immunology, Molecular biology, Interleukin 9, T cell and Antigen. She integrates Immunology with Indoleamine 2,3-dioxygenase in her study. Her study in Molecular biology is interdisciplinary in nature, drawing from both Tyrosine kinase, JAK-STAT signaling pathway, Interleukin-21 receptor and Complementary DNA, Molecular cloning.

The Interleukin 9 study combines topics in areas such as Cell biology, Growth factor and Interleukin 4. Her T cell study incorporates themes from Cytotoxic T cell and B cell. Her biological study spans a wide range of topics, including Epitope, Toxicity and Enzyme.

Her most cited work include:

  • Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase (1739 citations)
  • Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset (929 citations)
  • Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. (625 citations)

What are the main themes of her work throughout her whole career to date?

Catherine Uyttenhove mostly deals with Immunology, Molecular biology, Antigen, Immune system and Cancer research. Her Immunology study is mostly concerned with Antibody, Cytokine, Interleukin 17, T cell and Vaccination. Her Antibody study combines topics in areas such as Experimental autoimmune encephalomyelitis and Interleukin 12.

Her Molecular biology research also works with subjects such as

  • B cell and related Lymphokine,
  • Interleukin 9 which connect with Cell culture, Cell biology and Cell growth. Her work deals with themes such as Cancer immunotherapy, Mastocytoma and Virology, which intersect with Antigen. Her Cancer research research includes elements of Cancer, Cytotoxic T cell, CD40, CD8 and In vivo.

She most often published in these fields:

  • Immunology (70.92%)
  • Molecular biology (27.66%)
  • Antigen (25.53%)

What were the highlights of her more recent work (between 2011-2021)?

  • Immunology (70.92%)
  • Cancer research (26.95%)
  • Immune system (22.70%)

In recent papers she was focusing on the following fields of study:

Her scientific interests lie mostly in Immunology, Cancer research, Immune system, Antibody and Cancer. Inflammation, Interleukin 17, T cell, Neutralization and Cancer immunotherapy are the core of her Immunology study. She combines subjects such as CD8, Molecular biology, Graft-versus-host disease, Regulatory T cell and Cytotoxic T cell with her study of Cancer research.

Her work carried out in the field of Immune system brings together such families of science as DNA and Arthritis. Her work in Antibody addresses subjects such as Interleukin 12, which are connected to disciplines such as Mastocytoma and Immune protection. Her Cancer study combines topics from a wide range of disciplines, such as Transforming growth factor, Melanoma, Cytolysis and Virus.

Between 2011 and 2021, her most popular works were:

  • Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase (357 citations)
  • Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. (81 citations)
  • Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. (81 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Antibody

Catherine Uyttenhove focuses on Immunology, Cancer research, Inflammation, Molecular biology and Lung. The various areas that Catherine Uyttenhove examines in her Immunology study include Cancer and Melanoma. Her biological study spans a wide range of topics, including Immunohistochemistry, Cell, Cell migration and Cytotoxic T cell, Tumor antigen.

Catherine Uyttenhove works mostly in the field of Inflammation, limiting it down to topics relating to Cytokine and, in certain cases, Mesenteric lymph nodes, Intracellular parasite, Intracellular and Immunopathology, as a part of the same area of interest. Her work deals with themes such as B cell, Integrin, Periostin, Cell adhesion molecule and Monoclonal antibody, which intersect with Molecular biology. Her Lung research incorporates elements of Respiratory tract, Respiratory system and Polyethylene glycol, PEGylation.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

Catherine Uyttenhove;Luc Pilotte;Ivan Théate;Ivan Théate;Vincent Stroobant.
Nature Medicine (2003)

2494 Citations

Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset

Marc Veldhoen;Catherine Uyttenhove;Jacques van Snick;Helena Helmby.
Nature Immunology (2008)

1587 Citations

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.

J Van Snick;S Cayphas;A Vink;C Uyttenhove.
Proceedings of the National Academy of Sciences of the United States of America (1986)

852 Citations

Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice

David Bending;Hugo De La Peña;Marc Veldhoen;Jenny M. Phillips.
Journal of Clinical Investigation (2009)

659 Citations

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells

Wassim Elyaman;Elizabeth M. Bradshaw;Catherine Uyttenhove;Valérie Dardalhon.
Proceedings of the National Academy of Sciences of the United States of America (2009)

610 Citations

Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

Luc Pilotte;Pierre Larrieu;Vincent Stroobant;Didier Colau.
Proceedings of the National Academy of Sciences of the United States of America (2012)

532 Citations

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

Soraya Taleb;Mélissa Romain;Bhama Ramkhelawon;Catherine Uyttenhove.
Journal of Experimental Medicine (2009)

472 Citations

B cell depletion reduces the development of atherosclerosis in mice

Hafid Ait-Oufella;Olivier Herbin;Jean-David Bouaziz;Jean-David Bouaziz;Christoph J. Binder.
Journal of Experimental Medicine (2010)

435 Citations

Functional and structural characterization of P40, a mouse glycoprotein with T-cell growth factor activity

C Uyttenhove;R J Simpson;J Van Snick.
Proceedings of the National Academy of Sciences of the United States of America (1988)

388 Citations

Mast cell growth-enhancing activity (MEA) is structurally related and functionally identical to the novel mouse T cell growth factor P40/TCGFIII (interleukin 9).

Lothar Hültner;Catherine Druez;Jochen Moeller;Catherine Uyttenhove.
European Journal of Immunology (1990)

378 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Catherine Uyttenhove

Thierry Boon

Thierry Boon

Ludwig Cancer Research

Publications: 106

Jean-Christophe Renauld

Jean-Christophe Renauld

Université Catholique de Louvain

Publications: 106

Benoît Van den Eynde

Benoît Van den Eynde

Ludwig Cancer Research

Publications: 85

Ziad Mallat

Ziad Mallat

University of Cambridge

Publications: 61

Ursula Grohmann

Ursula Grohmann

University of Perugia

Publications: 60

Paolo Puccetti

Paolo Puccetti

University of Perugia

Publications: 59

Jacques Van Snick

Jacques Van Snick

Université Catholique de Louvain

Publications: 54

Thomas F. Gajewski

Thomas F. Gajewski

University of Chicago

Publications: 53

George C. Prendergast

George C. Prendergast

Lankenau Institute for Medical Research

Publications: 51

Francesca Fallarino

Francesca Fallarino

University of Perugia

Publications: 50

Andrew L. Mellor

Andrew L. Mellor

Newcastle University

Publications: 43

David H. Munn

David H. Munn

Augusta University

Publications: 43

Roberta Bianchi

Roberta Bianchi

University of Perugia

Publications: 41

Dietmar Fuchs

Dietmar Fuchs

Innsbruck Medical University

Publications: 41

Pierre Coulie

Pierre Coulie

Université Catholique de Louvain

Publications: 40

Christoph J. Binder

Christoph J. Binder

Medical University of Vienna

Publications: 38

Trending Scientists

Thomas F. La Porta

Thomas F. La Porta

Pennsylvania State University

Rubén Ruiz

Rubén Ruiz

Universitat Politècnica de València

Holger Ernst

Holger Ernst

WHU-Otto Beisheim School of Management

Ulrich Pinkall

Ulrich Pinkall

Technical University of Berlin

Etienne Barnard

Etienne Barnard

North-West University

Yang Zhao

Yang Zhao

Beijing Institute of Technology

José A. S. Cavaleiro

José A. S. Cavaleiro

University of Aveiro

Giacomo Carrea

Giacomo Carrea

National Research Council (CNR)

André Guillouzo

André Guillouzo

University of Rennes

Edouard M. Bevers

Edouard M. Bevers

Maastricht University

John H. Simpson

John H. Simpson

Bangor University

Stefano Poli

Stefano Poli

University of Milan

Marie-José Freund-Mercier

Marie-José Freund-Mercier

University of Strasbourg

Daniel Romer

Daniel Romer

University of Pennsylvania

Stephen Lam

Stephen Lam

University of British Columbia

Something went wrong. Please try again later.